This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of other and unspecified genital organs
CD2_INSITU_GENITAL_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly females |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D00-D09
- Name in latin
- Carcinoma in situ organorum genitalium aliorum sive non specificatorum
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of other and unspecified genital organs
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of other and unspecified genital organs
- In situ neoplasms
- In situ neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 603 | 603 | - |
| Unadjusted period prevalence (%) | 0.21 | 0.21 | - |
| Median age at first event (years) | 59.66 | 59.66 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 548
- Matched controls
- 5480
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
ULA02
NOMESCO Finland
Kolposcopy
28.4
234.6
363
353
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
63.8
203.3
234
63
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
1053.3
164.7
153
*
D07.0
ICD-10 Finland
Carcinoma in situ: Endometrium
+∞
152.4
139
*
8077/2-C51.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vulva, NOS
+∞
144.3
132
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
12.9
141.9
301
471
LEB00
NOMESCO Finland
Biopsy of vagina
48.8
134.5
163
47
8077/2-C52.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vagina, NOS
+∞
128.3
118
*
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
+∞
114.7
106
*
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
70.0
98.8
112
20
LEB30
NOMESCO Finland
Destruction of lesion of vaginal mucosa
110.9
93.6
100
11
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
92.3
86
*
N90.1
ICD-10 Finland
Moderate vulvar dysplasia
+∞
90.1
84
*
LFC00
NOMESCO Finland
Partial excision of vulva
462.8
82.3
80
*
N89.2
ICD-10 Finland
Severe vaginal dysplasia, not elsewhere classified
+∞
81.3
76
*
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
8.3
78.8
200
354
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
10.7
77.7
164
211
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
62.7
59
*
N89.1
ICD-10 Finland
Moderate vaginal dysplasia
144.5
61.3
64
5
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
22.9
60.8
89
46
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
582.6
54.5
53
*
B01AB10
ATC
tinzaparin; parenteral
10.9
50.9
102
112
PJA12
NOMESCO Finland
Sentinel node biopsy
522.0
49.2
48
*
115
Kela drug reimbursment
Breast cancer
+∞
48.7
46
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
8.3
46.4
110
161
D06BB10
ATC
imiquimod; topical
10.7
46.0
93
103
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
9.7
45.4
97
119
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
49.7
45.0
54
12
H02AB02
ATC
dexamethasone; systemic
28.0
42.5
58
23
LDA10
NOMESCO Finland
Curettage of cervix uteri
8.2
40.7
96
138
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
40.1
38
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
404.1
38.5
38
*
N89.0
ICD-10 Finland
Mild vaginal dysplasia
88.5
37.3
41
5
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.2
35.8
284
1378
128
Kela drug reimbursment
Cancers of female genital organs
369.6
35.4
35
*
N90.0
ICD-10 Finland
Mild vulvar dysplasia
52.3
33.0
39
8
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
32.6
31
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
31.6
30
*
XX3DW
NOMESCO Finland
Time consuming IT work
8.0
31.0
73
103
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
14.2
30.3
52
40
N87.0
ICD-10 Finland
Mild cervical dysplasia
9.0
27.7
60
74
JN4BD
NOMESCO Finland
Extensive body CT
7.2
26.7
67
104
8070/2-C51.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of vulva, NOS
+∞
26.3
25
*
ZXC96
NOMESCO Finland
Robot assisted procedure
28.6
26.1
35
13
N85.1
ICD-10 Finland
Endometrial adenomatous hyperplasia
19.9
26.0
39
21
A63.0
ICD-10 Finland
Anogenital (venereal) warts
8.7
25.9
57
72
HAC20
NOMESCO Finland
Total mastectomy
+∞
25.2
24
*
JN4AD
NOMESCO Finland
Body CT examination
10.1
24.8
50
54
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.9
24.8
58
81
HA1AA
NOMESCO Finland
X-ray mammography
6.7
24.7
65
108
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.8
24.6
116
361
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
10.6
24.0
47
48
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
6.9
24.0
62
100
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
130.7
23.8
25
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
23.1
22
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.7
22.9
205
995
WF002
NOMESCO Finland
Radical radiotherapy
125.2
22.8
24
*
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
13.4
22.5
39
31
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
22.0
21
*
8071/2-C51.9
ICD-O-3
Differentiated intraepithelial neoplasia of vulva, NOS
+∞
21.0
20
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
21.0
20
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.9
20.7
91
264
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
217.9
20.7
21
*
A04AA02
ATC
granisetron; systemic, transdermal
217.9
20.7
21
*
L02BA01
ATC
tamoxifen; oral
114.4
20.7
22
*
L02BG04
ATC
letrozole; oral
13.3
19.6
34
27
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
18.9
18
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
18.9
18
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
18.9
18
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
21.8
18.8
27
13
B01AB05
ATC
enoxaparin; parenteral
2.4
18.3
198
1036
HAB40
NOMESCO Finland
Wedge excision of mammary gland
16.0
18.2
29
19
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
+∞
17.8
17
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
17.8
17
*
D07AD01
ATC
clobetasol; topical
2.7
17.6
135
583
N95.0
ICD-10 Finland
Postmenopausal bleeding
3.1
17.3
104
381
130
Kela drug reimbursment
Malignant tumour
+∞
16.7
16
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
16.7
16
*
8070/3-C51.9
ICD-O-3
Squamous cell carcinoma, NOS, of vulva, NOS
+∞
16.7
16
*
C51.01
ICD-10 Finland
Squamous cell carcinoma of the labium majus
+∞
16.7
16
*
8380/3-C54.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of corpus uteri
+∞
16.7
16
*
D07.2
ICD-10 Finland
Carcinoma in situ: Vagina
+∞
16.7
16
*
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
17.0
16.7
26
16
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
175.0
16.6
17
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
175.0
16.6
17
*
LCA06
NOMESCO Finland
Biopsy of endometrium
2.7
16.0
123
526
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
61.9
15.8
18
*
D07.3
ICD-10 Finland
Carcinoma in situ: Other and unspecified female genital organs
+∞
15.7
15
*
N90.3
ICD-10 Finland
Dysplasia of vulva, unspecified
+∞
15.7
15
*
LEB10
NOMESCO Finland
Excision of lesion of vagina
19.9
15.7
23
12
N76.6
ICD-10 Finland
Ulceration of vulva
22.8
15.6
22
10
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
6.7
15.6
40
64
ZZR00
NOMESCO Finland
Flap of skin
39.3
15.5
19
5
N90.4
ICD-10 Finland
Leukoplakia of vulva
24.2
15.2
21
9
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
14.6
14
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
14.6
14
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
14.6
14
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
14.6
14
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
14.6
14
*
C51.11
ICD-10 Finland
Squamous cell carcinoma of the labium minus
+∞
14.6
14
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.3
14.3
77
261
A03FA01
ATC
metoclopramide; systemic, rectal
2.7
14.2
111
478
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
13.6
13
*
A04AD12
ATC
aprepitant; systemic
+∞
13.6
13
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
13.6
13
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
26.5
13.4
18
7
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
15.5
13.2
21
14
N87.1
ICD-10 Finland
Moderate cervical dysplasia
5.8
13.1
37
68
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
13.1
227
1419
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.1
12.8
28
36
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
12.5
12
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
12.5
12
*
C54.10
ICD-10 Finland
Malignant tumor of endometrium without histology
+∞
12.5
12
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
13.6
12.5
21
16
2333B
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Other and unspecified female genital organs[CARCINOMA IN SITU VULVAE]
+∞
11.5
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
C51.81
ICD-10 Finland
Squamous cell carcinoma of the vulva
+∞
11.5
11
*
A04AA01
ATC
ondansetron; systemic, rectal
5.3
11.4
34
67
ZXC10
NOMESCO Finland
Use of laser
6.6
11.2
28
44
L03AA02
ATC
filgrastim; parenteral
44.2
11.0
13
*
N84.0
ICD-10 Finland
Polyp of corpus uteri
2.7
10.7
79
326
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
13.2
10.7
18
14
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
8.8
10.6
22
26
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
+∞
10.4
10
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
10.4
10
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
10.4
10
*
8542/3-C51.9
ICD-O-3
Paget disease, extramammary of vulva, NOS
+∞
10.4
10
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
56.0
9.7
11
*
WZC30
NOMESCO Finland
Teaching
2.7
9.6
66
261
SPAT1153
SPAT
Removal of sutures
1.9
9.5
182
1150
D06BB04
ATC
podophyllotoxin; topical
3.9
9.4
38
103
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
9.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
9.4
9
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
9.4
9
*
8070/3-C52.9
ICD-O-3
Squamous cell carcinoma, NOS, of vagina, NOS
+∞
9.4
9
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
9.4
9
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
9.4
9
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
9.4
116
617
N02BE01
ATC
paracetamol; systemic, rectal
2.2
9.3
484
4246
N85.0
ICD-10 Finland
Endometrial glandular hyperplasia
5.1
9.2
28
57
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
9.3
9.1
18
20
ZX120
NOMESCO Finland
Intravenous
3.2
9.1
47
156
8474
FHL
Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia
12.8
8.9
15
12
UJF32
NOMESCO Finland
Coloscopy
1.9
8.8
152
921
J01DB01
ATC
cefalexin; oral
1.9
8.8
449
3843
J02AC01
ATC
fluconazole; systemic
1.7
8.7
289
2158
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
8.6
166
1047
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
91.4
8.4
9
*
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
2.9
8.4
52
193
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
8.4
8
*
LFD10
NOMESCO Finland
Vulvectomy and excision of regional lymph nodes
+∞
8.4
8
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
8.4
8
*
C51.9
ICD-10 Finland
Malignant neoplasm: Vulva, unspecified
+∞
8.4
8
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.4
8
*
E0000UV
ATC
NA
1.7
8.3
230
1618
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
14.7
8.2
13
9
N02AA05
ATC
oxycodone; systemic
2.5
8.2
64
273
P01AB01
ATC
metronidazole; oral, rectal
1.7
8.2
257
1874
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.1
8.0
24
49
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
7.9
47
172
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
6.1
7.7
20
34
E000001
ATC
NA
1.9
7.7
128
759
ZZF00
NOMESCO Finland
Graft of adipose tissue
25.4
7.6
10
*
A41.9
ICD-10 Finland
Sepsis, unspecified
5.9
7.6
20
35
G01AA10
ATC
clindamycin; vaginal
1.9
7.5
128
767
SPAT1312
SPAT
General health counselling
1.7
7.5
196
1346
X76
ICPC
Malignant neoplasm breast female
81.1
7.4
8
*
J01EA01
ATC
trimethoprim; systemic
1.7
7.3
179
1204
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
7.3
7
*
C52.91
ICD-10 Finland
Squamous cell carcinoma of the vagina
+∞
7.3
7
*
C54.14
ICD-10 Finland
Serous papillary carcinoma of the endometrium
+∞
7.3
7
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
7.3
7
*
LFD00
NOMESCO Finland
Vulvectomy
+∞
7.3
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.3
7
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
7.3
7
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
7.3
7
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
7.3
7
*
LCA13
NOMESCO Finland
Curettage of cervix and body of uterus
2.5
7.3
59
257
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
7.5
7.2
16
22
LWA00
NOMESCO Finland
Repair of wound dehiscence in gynaecological surgery
30.4
7.2
9
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
7.1
68
323
L57.0
ICD-10 Finland
Actinic keratosis
2.7
7.0
48
190
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
6.9
200
1407
R87.7
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal histological findings
14.0
6.9
11
8
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
6.9
89
480
8070/2-C53.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of cervix uteri
11.1
6.8
12
11
ULC02
NOMESCO Finland
Hysteroscopy
2.5
6.7
51
217
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
6.6
67
325
C03CA01
ATC
furosemide; systemic
1.8
6.5
137
875
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
70.6
6.4
7
*
C50
ICD-10 Finland
Malignant neoplasm of breast
70.6
6.4
7
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
70.6
6.4
7
*
TQW20
NOMESCO Finland
Tatoe
70.6
6.4
7
*
LFW96
NOMESCO Finland
Other operation on vulva or perineum
70.6
6.4
7
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.2
6.4
31
100
A02BC02
ATC
pantoprazole; systemic
1.6
6.3
351
2892
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
18.3
6.3
9
5
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
6.3
6
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
6.3
6
*
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
1CD02
NOMESCO Finland
NA
+∞
6.3
6
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
C51.00
ICD-10 Finland
Malignant tumor of the labium majus without histology
+∞
6.3
6
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
6.3
6
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
H02AB06
ATC
prednisolone; systemic
1.6
6.2
256
1958
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
6.4
6.2
15
24
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.6
6.2
363
3028
LFE10
NOMESCO Finland
Plastic repair of vulva
12.7
6.1
10
8
S18
ICPC
Laceration/cut
1.6
6.0
209
1529
Z51.5
ICD-10 Finland
Palliative care
6.1
6.0
15
25
L04AA06
ATC
mycophenolic acid; systemic
5.6
6.0
16
29
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
6.0
57
271
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
3.5
6.0
26
77
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
71
23
34.86
110.28
4.3
1.5
—
—
—
0
0
345
1235
5.19
89.48
3.0
1.4
—
—
—
0
0
141
264
6.67
75.64
3.3
1.4
—
—
—
0
0
414
2146
3.96
55.92
4.6
3.5
—
—
—
0
0
176
666
3.32
36.20
9.0
5.9
—
—
—
0
0
217
1039
2.70
28.17
2.2
1.9
—
—
—
0
0
329
1988
2.44
25.34
5.1
3.3
36.0
36.2
g/l
0.41
305
1835
250
1372
2.40
23.44
5.1
3.9
0.0
0.0
estimate
0.50
64
448
381
2636
2.21
19.09
4.9
3.7
0.0
0.0
estimate
0.80
66
440
376
2616
2.16
18.19
5.9
5.1
0.0
0.0
estimate
0.50
61
443
344
2342
2.09
17.26
6.8
3.2
9.3
10.3
umol/l
1.57
329
2182
380
2705
2.09
16.65
10.6
6.5
4.0
4.1
e9/l
0.81
347
2331
102
441
2.58
15.34
3.8
5.8
0.9
1.4
mmol/l
0.72
76
350
315
2152
1.97
14.81
5.1
4.4
1.2
1.2
mmol/l
4.26
275
1894
360
2593
1.96
14.29
4.9
3.7
0.0
0.0
estimate
0.00
63
448
199
1184
2.02
13.70
6.0
4.0
1.0
1.0
kg/l
1.02
19
177
91
394
2.54
13.58
2.0
2.0
60.8
68.0
ml/min/173m2
1.10
34
165
126
648
2.19
12.65
2.9
2.2
0.8
0.8
mmol/l
2.76
116
590
471
3808
2.08
12.46
9.2
5.1
78.9
75.2
u/l
1.19
450
3513
291
2019
1.85
12.27
5.2
3.8
—
—
—
0
0
330
2407
1.82
11.59
6.0
4.9
1.2
1.2
mmol/l
5.10
274
2040
363
2763
1.79
10.68
4.7
3.8
6.6
6.6
mmol/l
0.30
345
2547
61
249
2.61
10.21
3.3
1.4
3.2
2.6
ug/l
0.69
51
185
69
302
2.45
9.99
1.4
1.5
—
—
—
0
0
243
1684
1.74
9.62
3.7
2.0
2.4
2.4
mmol/l
0.72
208
1419
209
1400
1.75
9.25
3.1
2.8
1097.5
989.0
ng/l
0.16
182
1166
79
382
2.23
9.10
4.7
3.6
239.1
232.7
u/l
0.21
74
355
12
5
24.42
8.94
2.8
1.0
48.6
14.8
u/ml
—
12
5
79
400
2.12
8.10
2.6
2.3
2.7
6.3
ug/l
4.01
73
351
13
21
6.30
7.74
1.4
1.4
—
—
—
0
0
219
1552
1.65
7.55
3.6
2.1
53.0
56.7
u/l
1.10
206
1408
182
1234
1.68
7.42
4.0
2.8
0.3
0.4
e6/l
0.93
147
923
112
674
1.81
6.92
2.0
1.7
—
—
—
0
0
11
8
13.97
6.91
1.8
1.8
—
—
—
0
0
247
1837
1.58
6.82
4.1
3.4
21.0
45.3
ng/l
0.61
165
1172
27
92
3.03
6.35
2.8
3.0
—
—
—
0
0
23
73
3.24
6.07
1.1
1.2
—
—
—
0
0
52
251
2.17
6.02
1.4
1.5
—
—
—
0
0
557
5124
2.14
5.97
20.3
11.2
23.2
19.4
mg/l
1.69
463
3896
10
16
6.34
5.97
2.1
1.4
—
—
—
0
0
83
483
1.83
5.68
2.0
2.0
—
—
—
0
0
116
747
1.68
5.59
3.6
2.4
2.5
1.4
e6/l
0.51
83
398
75
429
1.85
5.42
2.0
1.9
—
—
—
0
0
24
85
2.90
5.30
1.5
1.7
—
—
—
0
0
572
5353
2.33
5.26
20.7
12.7
139.5
139.8
mmol/l
1.54
565
5204
92
565
1.74
5.26
38.0
22.6
1.3
1.3
inr
0.03
11
83
88
536
1.75
5.17
7.4
3.5
1.1
1.0
mmol/l
0.45
82
474
35
153
2.37
5.13
1.6
2.0
1.8
1.5
g/l
0.60
27
136
212
1602
1.50
5.10
2.5
2.1
130.6
143.6
u/l
0.38
202
1506
572
5367
2.28
4.98
20.8
12.8
4.0
3.9
mmol/l
0.54
564
5205
44
220
2.08
4.69
1.6
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
23
86
2.74
4.63
1.7
2.8
0.3
0.4
u/ml
1.32
11
54
52
281
1.93
4.48
1.9
1.7
—
—
—
0
0
449
3990
1.49
4.35
5.5
4.3
14.3
12.1
mm/h
2.26
414
3702
31
139
2.30
4.32
2.4
2.1
2140.9
4526.0
u/l
0.54
13
61
8
9
8.99
4.29
1.6
1.2
14.5
15.8
ug/l
—
8
9
579
5501
2.32
4.17
21.5
12.6
71.3
69.3
umol/l
0.85
579
5501
135
971
1.50
4.00
1.7
1.5
—
—
—
0
0
206
1613
1.42
3.91
4.2
3.0
6.4
6.5
mmol/l
0.17
168
1353
161
1205
1.46
3.90
2.7
2.1
7386.3
5125.7
umol/l
0.17
141
1025
75
473
1.67
3.89
2.1
1.7
—
—
—
0
0
84
554
1.60
3.66
3.0
2.3
22.2
23.1
%
0.23
71
465
155
1171
1.44
3.54
1.5
1.7
0.8
0.9
mg/l
0.80
118
886
99
686
1.53
3.48
2.8
2.2
12.1
13.7
umol/l
1.31
87
623
73
475
1.61
3.36
2.0
1.7
—
—
—
0
0
39
214
1.88
3.26
4.6
3.2
2.3
2.0
mmol/l
0.18
32
162
483
4439
1.44
3.21
5.3
4.5
15.0
14.7
pmol/l
1.40
445
4077
90
622
1.53
3.20
2.8
2.2
2.3
2.4
g/l
2.11
80
574
577
5526
2.02
3.20
13.7
8.8
23.8
23.1
u/l
0.60
565
5303
19
79
2.45
3.16
1.3
1.3
—
—
—
0
0
200
1608
1.36
3.12
4.5
3.8
11.9
6.0
mg/mmol
0.71
117
904
12
39
3.12
3.10
1.1
1.2
58.6
58.5
u/l
—
7
26
12
39
3.12
3.10
1.1
1.3
—
—
—
0
0
7
12
5.89
3.03
1.6
1.0
463.3
307.5
u/l
—
7
12
15
57
2.67
2.98
1.0
1.1
—
—
—
0
0
527
4944
1.52
2.97
15.2
9.9
79.8
80.3
ml/min/173m2
0.20
457
3938
14
52
2.73
2.90
1.5
1.4
—
—
—
0
0
125
941
1.41
2.87
3.2
2.1
2.5
2.4
mmol/l
1.63
109
829
57
367
1.61
2.76
3.7
2.7
2.1
2.2
mmol/l
0.12
46
297
12
42
2.89
2.76
1.5
1.5
—
—
—
0
0
17
72
2.40
2.75
1.5
1.5
—
—
—
0
0
17
72
2.40
2.75
1.2
1.2
—
—
—
0
0
11
38
2.93
2.59
1.2
1.2
—
—
—
0
0
30
165
1.86
2.54
1.9
1.8
—
—
—
0
0
17
75
2.30
2.53
1.8
1.4
—
—
—
0
0
17
75
2.30
2.53
1.8
1.4
—
—
—
0
0
9
26
3.50
2.49
1.2
1.5
—
—
—
0
0
68
473
1.49
2.37
1.9
1.5
1.4
1.3
%
0.15
59
422
28
157
1.82
2.25
1.8
1.7
—
—
—
0
0
21
107
2.00
2.23
1.3
1.6
—
—
—
0
0
68
480
1.47
2.22
4.2
1.8
5.3
5.1
umol/l
0.09
60
408
13
54
2.44
2.21
2.1
1.3
—
—
—
0
0
124
975
1.34
2.17
1.7
1.7
1336.1
1207.8
nmol/l
0.78
98
714
185
1540
1.29
2.15
4.4
2.4
30.9
28.8
u/l
0.48
170
1477
15
68
2.24
2.12
1.6
1.5
—
—
—
0
0
10
37
2.73
2.11
1.2
1.1
—
—
—
0
0
30
178
1.72
2.02
3.7
2.8
24.3
24.6
mmol/l
0.19
24
160
530
5061
1.39
1.90
4.4
4.0
1.3
1.3
mmol/l
1.61
482
4615
29
174
1.70
1.89
1.2
1.1
—
—
—
0
0
12
52
2.33
1.88
1.2
1.4
—
—
—
0
0
34
214
1.62
1.86
8.7
5.9
25.0
25.1
mmol/l
0.04
34
214
29
175
1.69
1.86
1.2
1.1
—
—
—
0
0
11
46
2.42
1.86
1.2
1.3
—
—
—
0
0
147
1212
1.28
1.82
1.5
1.5
22.8
22.4
nmol/l
0.09
125
1023
9
35
2.59
1.80
1.6
1.5
—
—
—
0
0
8
29
2.78
1.79
1.3
1.3
—
—
—
0
0
249
2188
1.24
1.77
2.0
2.0
99.6
100.0
pmol/l
0.04
130
1028
587
5736
1.88
1.74
29.2
17.0
131.3
132.8
g/l
2.17
581
5649
27
163
1.69
1.74
2.4
4.5
1.7
1.5
%
0.61
27
157
7
24
2.94
1.72
1.9
1.3
—
—
—
0
0
7
24
2.94
1.72
2.1
1.3
—
—
—
0
0
0
48
0.00
1.70
0.0
1.5
—
1.2
—
0
42
515
4920
1.32
1.63
6.3
5.7
39.5
39.5
mmol/mol
0.01
477
4564
7
26
2.71
1.58
1.1
1.2
—
—
—
0
0
7
26
2.71
1.58
1.1
1.2
—
—
—
0
0
7
26
2.71
1.58
1.1
1.2
—
—
—
0
0
352
3235
1.21
1.53
3.9
2.8
59.1
39.4
u/l
1.46
327
2998
35
235
1.52
1.50
1.5
1.5
—
—
—
0
0
18
101
1.81
1.50
2.7
1.9
125.6
131.5
g/l
0.38
11
72
57
423
1.38
1.47
4.1
3.1
92.5
78.1
ng/l
0.74
52
374
31
204
1.55
1.46
3.5
2.6
24.7
25.6
mmol/l
1.09
31
197
5
16
3.14
1.44
1.0
1.3
—
—
—
0
0
5
16
3.14
1.44
1.0
1.3
—
—
—
0
0
147
1250
1.23
1.39
2.7
2.2
3.7
2.9
mg/l
2.38
125
1048
15
84
1.81
1.28
14.7
3.5
5.2
5.1
kpa
0.05
15
84
8
35
2.30
1.27
1.3
1.3
—
—
—
0
0
264
2393
1.18
1.25
2.4
2.3
81.1
79.8
nmol/l
0.30
227
2125
59
453
1.34
1.25
3.3
2.9
—
—
—
0
0
8
36
2.24
1.24
2.5
2.1
—
—
—
0
0
14
78
1.81
1.22
1.6
1.5
—
—
—
0
0
20
125
1.62
1.19
1.2
1.2
—
—
—
0
0
8
38
2.12
1.18
1.1
1.0
—
—
—
0
0
13
72
1.82
1.16
1.5
1.6
60.6
59.4
%
—
8
45
524
5065
1.26
1.15
6.2
5.4
2.0
2.1
mu/l
0.21
485
4665
552
5372
1.33
1.13
5.5
5.0
2.8
2.8
mmol/l
0.81
504
4951
28
192
1.48
1.13
2.5
2.1
1.2
1.1
%
0.44
28
192
26
176
1.50
1.12
1.4
1.2
6.0
2.3
u/ml
—
5
20
5
21
2.39
1.09
1.0
1.2
—
—
—
0
0
48
369
1.33
1.04
3.4
3.0
4.5
4.5
pmol/l
0.02
41
316
82
677
1.24
1.03
4.2
2.6
3.7
4.7
e6/l
0.47
49
328
26
180
1.46
1.02
1.4
1.3
2.7
10.8
u/ml
—
6
36
46
353
1.33
1.01
1.9
1.4
63.1
67.8
g/l
2.12
38
320
7
35
2.01
1.00
1.0
1.1
—
—
—
0
0
35
259
1.37
0.97
3.3
2.5
121.1
127.7
g/l
1.11
35
249
257
2362
1.15
0.97
2.9
2.8
116.8
82.8
ug/l
1.76
234
2173
47
366
1.31
0.95
5.8
2.3
1.2
1.2
mmol/l
0.76
38
298
18
118
1.54
0.92
1.5
1.6
—
—
—
0
0
40
306
1.33
0.91
1.4
1.3
—
—
—
0
0
17
110
1.56
0.91
1.2
1.2
—
—
—
0
0
132
1495
0.85
0.90
1.7
1.6
1.5
1.4
mmol/l
0.76
107
1275
15
228
0.65
0.87
1.3
1.8
3.3
4.7
mg/l
—
10
163
21
146
1.45
0.83
1.2
1.4
321.3
325.5
ug/g
—
10
81
81
688
1.20
0.80
3.9
4.6
33.1
33.7
%
0.17
52
447
533
5201
1.21
0.79
5.4
4.6
5.9
5.9
mmol/l
1.06
493
4748
0
25
0.00
0.79
0.0
1.4
—
9.0
—
0
25
23
165
1.41
0.79
1.4
1.3
290.8
235.4
miu/ml
0.34
12
76
540
5278
1.22
0.77
5.0
4.5
4.8
4.9
mmol/l
1.44
498
4886
29
218
1.35
0.76
3.6
2.2
40.4
40.7
u/l
0.02
23
194
6
34
1.77
0.76
1.5
1.4
—
—
—
0
0
410
4265
0.88
0.76
20.8
13.5
13.8
13.6
%
2.66
400
4159
16
108
1.49
0.74
3.1
2.4
32.9
46.7
ug/min
—
7
67
5
25
2.01
0.73
4.6
2.6
486.6
1199.5
u/ml
—
5
25
13
84
1.56
0.72
3.6
2.2
15.6
16.5
%
—
8
37
536
5242
1.20
0.72
4.8
4.5
1.5
1.6
mmol/l
1.82
488
4831
9
58
1.56
0.70
1.6
1.1
—
—
—
0
0
9
59
1.53
0.68
1.6
1.1
—
—
—
0
0
9
59
1.53
0.68
1.6
1.1
—
—
—
0
0
120
1071
1.15
0.67
1.3
1.3
6.3
11.3
u/ml
0.53
50
412
38
304
1.27
0.67
1.1
1.0
—
—
—
0
0
19
138
1.39
0.63
1.1
1.1
—
—
—
0
0
120
1077
1.14
0.63
1.4
1.3
24.4
37.7
iu/ml
0.98
32
365
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
10
64
1.57
0.59
1.4
1.2
—
—
—
0
0
18
132
1.37
0.57
1.8
1.9
148.2
169.1
ug/l
0.19
18
118
6
36
1.67
0.57
1.0
1.4
—
—
—
0
0
27
212
1.29
0.56
4.7
1.8
—
—
—
0
0
6
37
1.63
0.55
1.7
1.2
—
—
—
0
0
6
38
1.58
0.54
1.0
1.3
—
—
—
0
0
9
61
1.48
0.54
1.6
1.1
—
—
—
0
0
9
61
1.48
0.54
1.6
1.1
—
—
—
0
0
9
61
1.48
0.54
1.6
1.1
—
—
—
0
0
15
203
0.73
0.52
1.3
1.5
—
—
—
0
0
13
178
0.72
0.49
1.7
1.8
—
—
—
0
0
7
47
1.49
0.47
1.0
1.2
—
—
—
0
0
7
48
1.46
0.47
1.0
1.2
—
—
—
0
0
123
1133
1.11
0.44
1.6
1.7
453.1
28480105.6
pmol/l
1.31
102
934
18
140
1.29
0.42
2.2
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
79.0
—
0
6
52
456
1.15
0.41
1.2
1.2
94.1
145.4
iu/ml
0.86
22
191
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
38
442
0.85
0.40
1.7
1.7
—
—
—
0
0
7
101
0.69
0.40
1.3
1.3
—
—
—
0
0
30
252
1.20
0.38
1.4
1.6
—
—
—
0
0
13
98
1.33
0.37
4.5
3.2
3.4
4.3
e9/l
1.69
13
98
14
108
1.30
0.35
2.6
3.7
19.0
21.7
mg/l
—
7
66
13
100
1.31
0.34
4.8
3.5
56.9
59.4
%
0.30
13
100
10
75
1.34
0.30
5.2
5.3
315.5
378.7
umol/l
—
10
63
17
140
1.22
0.27
1.4
1.3
—
—
—
0
0
18
153
1.18
0.22
1.9
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
109.3
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
89.0
—
0
12
0
13
0.00
0.21
0.0
3.2
—
6.1
—
0
7
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
85.5
—
0
6
43
394
1.10
0.20
2.3
3.0
245.7
183.3
ng/l
0.31
37
367
47
433
1.09
0.20
3.0
1.8
29.1
34.2
u/l
0.70
37
356
12
101
1.19
0.16
1.6
1.2
—
—
—
0
0
8
71
1.13
0.16
3.5
1.4
—
—
—
0
0
12
140
0.85
0.15
1.3
1.2
33.6
38.3
g/l
—
7
124
471
4667
1.04
0.14
16.2
12.6
38.9
39.2
%
0.30
298
3308
14
125
1.12
0.10
1.4
1.5
—
—
—
0
0
12
135
0.89
0.10
1.3
1.2
3.6
3.8
mmol/l
0.63
12
123
6
58
1.03
0.08
1.2
1.1
—
—
—
0
0
7
65
1.08
0.08
1.0
1.0
—
—
—
0
0
7
66
1.06
0.08
1.0
1.2
—
—
—
0
0
6
73
0.82
0.07
1.3
1.0
—
—
—
0
0
6
74
0.81
0.07
1.0
1.1
127.0
120.1
%
—
6
68
16
173
0.92
0.06
1.7
2.0
2.1
5.7
iu/l
—
6
64
327
3243
1.02
0.06
3.2
3.0
—
—
—
0
0
129
1267
1.02
0.06
1.3
1.3
0.8
1.9
u/ml
1.77
27
334
94
922
1.02
0.05
3.5
3.8
80.4
339.6
ng/l
1.75
66
681
13
139
0.93
0.03
1.3
1.5
—
—
—
0
0
16
164
0.97
0.00
1.7
1.6
—
435.6
—
0
9
15
147
1.02
0.00
1.3
1.3
434.0
468.5
mg/l
0.20
15
135
12
118
1.02
0.00
1.2
1.4
—
—
—
0
0
12
118
1.02
0.00
1.3
1.4
—
—
—
0
0
15
148
1.01
0.00
2.4
1.3
1.2
0.3
g/l
—
9
135
17
168
1.01
0.00
1.5
1.3
7.2
10.3
g/l
—
9
146
17
168
1.01
0.00
2.1
1.3
3.1
3.0
g/l
—
8
135
12
119
1.01
0.00
1.2
1.4
—
—
—
0
0
12
119
1.01
0.00
1.2
1.4
—
—
—
0
0
18
179
1.01
0.00
2.0
1.3
7.5
7.6
g/l
—
8
137
18
179
1.01
0.00
2.0
1.3
3.8
3.7
g/l
—
8
132
18
179
1.01
0.00
2.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
8
87
0.92
0.00
2.4
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
6
65
0.92
0.00
1.0
1.2
—
—
—
0
0
6
65
0.92
0.00
1.2
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
108.3
—
0
7
0
8
0.00
0.00
0.0
2.1
—
0.6
—
0
8
7
77
0.91
0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_GENITAL_EXALLC – Carcinoma in situ of other and unspecified genital organs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).